Manning & Napier Group's GH Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 16 shares of Guardant Health, Inc. (GH) worth $2,460, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Manning & Napier Group has initiated a new position in GH, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Guardant Health (GH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Guardant Health (GH) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +16 | New Buy | 16 | $153.75 |
Manning & Napier Group's Guardant Health Investment FAQs
Manning & Napier Group first purchased Guardant Health, Inc. (GH) in Q2 2026, acquiring 16 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Guardant Health, Inc. (GH) for 1 quarters since Q2 2026.
Manning & Napier Group's largest addition to Guardant Health, Inc. (GH) was in Q2 2026, adding 16 shares worth $2,460.
According to the latest 13F filing for Q2 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 16 shares of Guardant Health, Inc. (GH), valued at approximately $2,460.
As of the Q2 2026 filing, Guardant Health, Inc. (GH) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Guardant Health, Inc. (GH) was 16 shares, as reported at the end of Q2 2026.